|
Following the transfer of the trading of the shares of Lavipharm (Greece) to the 'Under Surveillance' Category of the Athens Exchange, FTSE/ATHEX announces the following changes:
| INDEX |
CHANGE |
EFFECTIVE FROM
START OF TRADING |
| FTSE/ATHEX Mid Cap Index |
Lavipharm (Greece, 4726807) will be deleted from the index.
Mochlos (Greece, B6W1KX5) will be added to the index with a shares in issue total of 4,588,137 and an investability weighting of 50%. |
31 July 2012 |
| FTSE/ATHEX Small Cap Index |
Mochlos will be deleted from the index. |
31 July 2012 |
| FTSE/ATHEX Market Index |
Lavipharm will be deleted from the index. |
31 July 2012 |
For index related enquiries or further information about FTSE/ATHEX indices please contact:
| Client Services in UK: |
Tel: +44 (0) 20 7866 1810 |
| Client Services in US: |
New York: (Domestic) + 1 888 747 FTSE (3873) / (International): +1 212 314 1139 |
| Client Services in Asia Pacific: |
Hong Kong: + 852 2164 3333 Australia:(Domestic Toll-Free) + 1800 653 680 / (International) + 61 (2) 9293 2864 Japan + 81 (3) 3581 2764 |
| Athens Stock Exchange: |
Tel: +30-1-33.66.217 or +30-1-33.66.216 |
Or, email your enquiries to info@ftse.com or visit our website at www.ftse.com, or visit www.ase.gr
|
